Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Lymphotoxin β receptor signalling executes Helicobacter pylori-driven gastric inflammation in a T4SS-dependent manner.
Gut 66, 1369-1381 (2016)
Objective Lymphotoxin ß receptor (LTßR) signalling has been implicated in inflammation-associated tumour development in different tissues. We have analysed the role of LTßR and alternative NF-κB signalling in Helicobacter pylori-mediated gastric inflammation and pathology. Design We analysed several ligands and receptors of the alternative NF-κB pathway, RelB, p52 nuclear translocation and target genes in tissue samples of H. pylori-infected patients with different degrees of gastritis or early gastric tumours by in situ hybridisation, immunohistochemistry, Western blot and real-time PCR analyses. Molecular mechanisms involved in LTßR activation by H. pylori were assessed in vitro using human gastric cancer cell lines and distinct H. pylori isolates. The effects of blocking or agonistically activating LTßR on gastric pathology during challenge with a human pathogenic H. pylori strain were studied in a mouse model. Results Among the tested candidates, LT was significantly increased and activated alternative NF-κB signalling was observed in the gastric mucosa of H. pylori-infected patients. H. pylori induced LTßR-ligand expression in a type IV secretion system-dependent but CagA-independent manner, resulting in activation of the alternative NF-κB pathway, which was further enhanced by blocking canonical NF-κB during infection. Blocking LTßR signalling in vivo suppressed H. pylori-driven gastritis, whereas LTßR activation in gastric epithelial cells of infected mice induced a broadened pro-inflammatory chemokine milieu, resulting in exacerbated pathology. Conclusions LTßR-triggered activation of alternative NF- κB signalling in gastric epithelial cells executes H. pyloriinduced chronic gastritis, representing a novel target to restrict gastric inflammation and pathology elicited by H. pylori, while exclusively targeting canonical NF-κB may aggravate pathology by enhancing the alternative pathway.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
14.921
3.862
19
22
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Epithelial Cells ; Helicobacter Pylori - Gastritis ; Helicobacter Pylori - Pathogenesis; Nf-kappa-b; Epithelial-cells; Alternative Pathway; Lymphoid Follicles; Virulence Factors; Nf-kappa-b2 P100; Prostate-cancer; Gene-expression; Activation; Kinase
Sprache
englisch
Veröffentlichungsjahr
2016
HGF-Berichtsjahr
2016
ISSN (print) / ISBN
0017-5749
e-ISSN
1468-3288
Zeitschrift
Gut (eGut)
Quellenangaben
Band: 66,
Heft: 8,
Seiten: 1369-1381
Verlag
BMJ Publishing Group
Verlagsort
London
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30201 - Metabolic Health
30201 - Metabolic Health
Forschungsfeld(er)
Immune Response and Infection
Genetics and Epidemiology
Genetics and Epidemiology
PSP-Element(e)
G-551600-001
G-500600-001
G-500600-001
PubMed ID
27196595
WOS ID
WOS:000405191200006
Scopus ID
84965022086
Erfassungsdatum
2016-05-19